First Fiduciary Investment Counsel Inc. increased its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 3.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 61,253 shares of the company's stock after buying an additional 1,856 shares during the quarter. Procter & Gamble accounts for about 1.9% of First Fiduciary Investment Counsel Inc.'s investment portfolio, making the stock its 25th largest position. First Fiduciary Investment Counsel Inc.'s holdings in Procter & Gamble were worth $9,759,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Stableford Capital II LLC boosted its holdings in shares of Procter & Gamble by 1.1% in the first quarter. Stableford Capital II LLC now owns 5,817 shares of the company's stock worth $993,000 after buying an additional 61 shares during the last quarter. Bernard Wealth Management Corp. boosted its holdings in shares of Procter & Gamble by 20.2% in the first quarter. Bernard Wealth Management Corp. now owns 375 shares of the company's stock worth $64,000 after buying an additional 63 shares during the last quarter. B & T Capital Management DBA Alpha Capital Management boosted its holdings in shares of Procter & Gamble by 2.3% in the first quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company's stock worth $476,000 after buying an additional 63 shares during the last quarter. Private Management Group Inc. lifted its holdings in Procter & Gamble by 4.8% during the first quarter. Private Management Group Inc. now owns 1,384 shares of the company's stock valued at $236,000 after purchasing an additional 64 shares in the last quarter. Finally, Lantz Financial LLC lifted its holdings in Procter & Gamble by 1.2% during the second quarter. Lantz Financial LLC now owns 5,237 shares of the company's stock valued at $834,000 after purchasing an additional 64 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.
Insider Buying and Selling
In related news, insider Balaji Purushothaman sold 490 shares of the business's stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $74,592.70. Following the sale, the insider owned 12,616 shares in the company, valued at approximately $1,920,533.68. The trade was a 3.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Andre Schulten sold 4,252 shares of the business's stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $647,281.96. Following the completion of the sale, the chief financial officer owned 53,992 shares in the company, valued at $8,219,202.16. This represents a 7.30% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock valued at $23,421,279 in the last three months. Corporate insiders own 0.20% of the company's stock.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on the stock. Wells Fargo & Company lowered their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a report on Thursday, September 25th. Berenberg Bank lifted their price target on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a report on Wednesday, September 17th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Procter & Gamble in a report on Wednesday. BNP Paribas Exane lowered their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a report on Tuesday, September 23rd. Finally, Barclays lowered their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 1st. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. According to MarketBeat, Procter & Gamble has an average rating of "Moderate Buy" and an average target price of $172.21.
View Our Latest Report on PG
Procter & Gamble Trading Down 0.6%
Procter & Gamble stock opened at $149.69 on Friday. The stock has a market cap of $350.34 billion, a P/E ratio of 22.99, a PEG ratio of 3.99 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. Procter & Gamble Company has a 1 year low of $149.45 and a 1 year high of $180.43. The firm's 50 day moving average price is $155.24 and its 200-day moving average price is $159.53.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.